Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Update

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 67,000 shares, a growth of 73.6% from the March 15th total of 38,600 shares. Currently, 2.0% of the company’s shares are short sold. Based on an average daily volume of 193,600 shares, the days-to-cover ratio is presently 0.3 days.

Shuttle Pharmaceuticals Price Performance

NASDAQ SHPH opened at $0.26 on Thursday. The stock has a market capitalization of $1.60 million, a P/E ratio of -0.06 and a beta of -1.04. The business has a 50 day simple moving average of $0.49 and a 200 day simple moving average of $0.81. Shuttle Pharmaceuticals has a one year low of $0.23 and a one year high of $4.71.

About Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .